Typicality: | 0.568 |
Saliency: | 0.366 |
randomly | 38 | manner |
to receive either an experimental treatment | 5 | purpose |
in each cohort | 4 | location |
subject → be assigned to receive → placebo | 23 |
subject → be assigned to → placebo | 18 |
subject → be assigned → placebo | 6 |
subject → be assigned to → the placebo | 3 |
negative | neutral | positive |
0.141 | 0.815 | 0.044 |
Raw frequency | 50 |
Normalized frequency | 0.366 |
Modifier score | 1.000 |
Perplexity | 46.874 |